- Home
- /
- Treatment
- /
- Page 31
Treatments
The following database contains products that have been granted orphan status, or have been market approval in the EU or the USA.
You can filter the content by clicking on the titles: Product, Indication, Sponsor and Date. Clicking once, will filter the column alphabetically from A – Z and a second click on the same title will filter from Z – A.
Become a Partner.
| Country | Product | Indication | Sponsor | Date |
|---|---|---|---|---|
|
Triheptanoin | McArdle’s disease | Vall d'Hebron Institute of Research | July 14, 2016 |
|
Sodium hypochlorite | Partial deep dermal and full thickness burns | Hypo-Stream Ltd | July 14, 2016 |
|
Volanesorsen sodium | Lipodystrophy | Ionis USA Limited | July 14, 2016 |
|
2-[4-(1-methyl-4-pyridin-4-yl-1H-pyrazol-3-yl)-phenoxymethyl]-quinoline succinic acid | Huntington disease | Pfizer Limited | July 14, 2016 |
|
Dimethyl fumarate | Bullous pemphigoid | Immungenetics AG | July 14, 2016 |
|
3-[4-(1H-imidazol-1-ylmethyl)phenyl]-5-(2-methylpropyl)thiophene-2-[(N-butyloxylcarbamate)-sulphonamide] sodium salt | Idiopathic pulmonary fibrosis | Vicore Pharma AB | July 14, 2016 |
|
Mifamurtide | Alveolar echinococcosis | Delta Proteomics SAS | July 14, 2016 |
|
Adeno-associated viral vector serotype 2.7m8 containing theChrimsonR-tdTomatogene | Retinitis pigmentosa | GenSight- Biologics | July 14, 2016 |
|
Mifamurtide | Hepatocellular Carcinoma | Delta Proteomics SAS | July 14, 2016 |
|
Autologous Epstein-Barr virus specific T-cells derived from peripheral blood mononuclear cells, expanded ex vivo | Extranodal NK/T-cell lymphoma, nasal type | Cell Medica Ltd. | July 14, 2016 |
|
Sodium benzoate | Ornithine Transcarbamylase Deficiency | Lucane Pharma SA | July 14, 2016 |
|
Autologous Epstein-Barr virus specific T-cells derived from peripheral blood mononuclear cells, expanded ex vivo | Post-transplant lymphoproliferative disorder | Cell Medica Ltd. | July 14, 2016 |
|
Brincidofovir | Adenovirus infection in immunocompromised patients | Chimerix UK Ltd | July 14, 2016 |
|
Poly(oxy-1,2-ethanediyl), alpha-(carboxymethyl)-omega-methoxy-,amide with arginase 1 [cobalt cofactor] (synthetic human) (1:10), trimer | Hyperargininaemia | ERA Consulting GmbH | July 14, 2016 |
|
Recombinant human monoclonal antibody to insulin receptor | Congenital hyperinsulinism | XOMA UK Limited | July 14, 2016 |
|
Setmelanotide | Pro-opiomelanocortin Deficiency | TMC Pharma Services Ltd | July 14, 2016 |
|
[F18] florilglutamic acid | Hepatocellular Carcinoma | Piramal Imaging S.A.;13 Route de l'Ecole;Matran | July 13, 2016 |
|
Tolfenamic acid | Frontotemporal dementia | Nasser H. Zawia;83 Castle Rocks Road;Warwick, Rhode Island, 02886 | July 13, 2016 |
|
Tolfenamic acid | Progressive supranuclear palsy | Nasser H. Zawia;83 Castle Rocks Road;Warwick, Rhode Island, 02886 | July 13, 2016 |
|
Recombinant human biglycan | Duchenne muscular dystrophy | Tivorsan Pharmaceuticals, Inc.;3 Davol Square, A340;Providence, Rhode Island, 02903 | July 13, 2016 |
|
[F18] florilglutamic acid | Hepatocellular Carcinoma | Piramal Imaging S.A.;13 Route de l'Ecole;Matran | July 13, 2016 |
|
1-(2-chlorophenyl)-1-(S)-hydroxy-2-(S)-carbamoyloxy-propane | Status epilepticus | Bio-Pharm Solutions Co., Ltd.;Advanced Institute of Convergence Technology, 6F, C Bldg;Yeongtong Suwon | July 7, 2016 |
|
Brentuximab vedotin | Enteropathy-associated T-cell lymphoma | Seattle Genetics, Inc.;21823 30th Drive Southeast;Bothell, Washington, 98021 | July 7, 2016 |
|
Selinexor | Soft tissue sarcoma | Karyopharm Therapeutics, Inc.;85 Wells Avenue;Newton, Maryland, 02459 | July 7, 2016 |
|
Deoxythymidine monophosphate and deoxycytidine monophosphate | Thymidine kinase 2 deficiency | Columbia University Medical Center;Department of Neurology, 630 West 168th Street, P&S; 4-423;New York, New York, 10032 | July 7, 2016 |
